Hollow fiber assay microtube array membrane (MTAM-HFA) for personalized anticancer drug screening in selection of concurrent chemoradiotherapy in oral squamous cell carcinoma.
Researchers tested a laboratory screening method (MTAM-HFA) to predict which chemotherapy drugs would work best for oral cancer patients undergoing combined chemotherapy and radiation. The method successfully predicted treatment responses in all three patients studied, suggesting potential as a personalised treatment selection tool.
A plain-English summary of the study's own findings — we don't add our own claims or interpretation. Read the full paper for the complete methods and results, and apply your own clinical judgement.
Read the full study at the sourceThe Recall — the month's most significant new dental research, summarised. Free.
Browse The Recall